Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

12112studies shown

Showing 3,025-3,036 of 12,112

Drug study icon

RecruitingNCT04123314

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Baltimore

DepressionOtherFrom 18 Years to 85 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT06378229

Psilocybin for Hospitalized people with Treatment-resistant Depression

This study is recruiting. It focuses on depression and currently lists participation information in Belgium.

In Ghent

DepressionDrugOver 18 Years

Countries: Belgium
Sponsor: University Hospital, Ghent
Condition: Depression

Drug study icon

RecruitingNCT04754061

PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)

This study is recruiting. It focuses on depression and currently lists participation information in Canada.

In Ottawa

Depression, AnxietyDrugOver 18 Years

Countries: Canada
Sponsor: Ottawa Hospital Research Institute
Condition: Depression, Anxiety

Drug study icon

RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

This study is recruiting. It focuses on depression and currently lists participation information in Canada.

In Toronto

DepressionOtherFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Depression

Drug study icon

RecruitingNCT06355414

Psilocybin in Chronic Low Back Pain and Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Baltimore

DepressionDrugFrom 21 Years to 80 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT07183748

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression

This study is recruiting. It focuses on depression and currently lists participation information in Israel.

In Beersheba

DepressionDrugFrom 18 Years to 65 Years

Countries: Israel
Sponsor: Beersheva Mental Health Center
Condition: Depression

Drug study icon

RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Austin

DepressionDrugFrom 22 Years to 65 Years

Countries: United States
Sponsor: University of Texas at Austin
Condition: Depression

Drug study icon

RecruitingNCT06455293

Psilocybin Therapy for Depression in Parkinson's Disease

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In San Francisco

DepressionOtherFrom 40 Years to 80 Years

Countries: United States
Sponsor: Joshua Woolley, MD, PhD
Condition: Depression

Drug study icon

RecruitingNCT06782724

Psilocybin Therapy for Psychological Distress in Palliative Patients

This study is recruiting. It focuses on depression and currently lists participation information in Czech Republic, Denmark, the Netherlands, and Portugal.

Multiple locations, including Prague

DepressionOtherOver 18 Years

Countries: Czechia, Denmark, Netherlands, ...
Sponsor: University Medical Center Groningen
Condition: Depression

Drug study icon

RecruitingNCT07251491

Psilocybin to Treat Depression in Spinal Cord Injury

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In The Bronx

DepressionOtherOver 22 Years

Countries: United States
Sponsor: James J. Peters Veterans Affairs Medical Center
Condition: Depression

Drug study icon

RecruitingNCT07347405

Psilocybin Whole Mushroom for OCD.

This study is recruiting. It focuses on OCD and currently lists participation information in the United States.

In Tucson

OCDOtherOver 18 Years

Countries: United States
Sponsor: Francisco A Moreno
Condition: OCD

Drug study icon

RecruitingNCT06592833

Psilocybin With Pimavanserin Compared to Psilocybin Alone for Major Depressive Disorder

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In New York

DepressionDrugFrom 21 Years to 80 Years

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.

Mental Health | Clinical Trials | HopeStage Research